Alamar Biosciences, Inc.
ALMR
$29.35
-$0.61-2.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.05M | 64.59M | -- | ||
| Total Receivables | 20.34M | 19.52M | -- | ||
| Inventory | 45.41M | 39.93M | -- | ||
| Prepaid Expenses | 15.58M | 17.43M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 331.38M | 141.47M | -- | ||
|
|
|||||
| Total Current Assets | 331.38M | 141.47M | -- | ||
| Net Property, Plant & Equipment | 49.16M | 36.14M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | 1.61M | 1.84M | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 8.83M | 7.00M | -- | ||
| Total Assets | 390.98M | 186.45M | -- | ||
|
|
|||||
| Total Accounts Payable | 13.79M | 5.64M | -- | ||
| Total Accrued Expenses | 8.71M | 11.63M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 2.28M | 1.60M | -- | ||
| Total Finance Division Other Current Liabilities | 3.18M | 5.18M | -- | ||
| Total Other Current Liabilities | 3.18M | 5.18M | -- | ||
| Total Current Liabilities | 27.96M | 24.05M | -- | ||
|
|
|||||
| Total Current Liabilities | 27.96M | 24.05M | -- | ||
| Long-Term Debt | 9.95M | 74.97M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 39.18M | 28.98M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 1.03M | 1.53M | -- | ||
| Total Liabilities | 78.12M | 129.53M | -- | ||
|
|
|||||
| Common Stock & APIC | 516.30M | 12.11M | -- | ||
| Retained Earnings | -203.30M | -190.10M | -- | ||
| Treasury Stock & Other | -139.00K | -80.00K | -- | ||
| Total Common Equity | 312.86M | -178.07M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 235.00M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 235.00M | -- | ||
|
|
|||||
| Total Common Equity | 312.86M | -178.07M | -- | ||
| Total Preferred Equity | -- | 235.00M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 312.86M | 56.93M | -- | ||
|
|
|||||